FDA warnings target smaller companies and leave the big boys alone, study finds

A recent study has revealed that the warning letters issued by the US Food and Drug Administration (FDA) target small online retailers rather than large e-cigarette brands or products most used by young people, such as disposables and pods.

FDA warnings to e-cigarette companies in 2020 and 2021 were almost all sent to small online retailers, according to analysis by the Truth Initiative.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ FDA warnings target smaller companies and leave the big boys alone, study finds ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ FDA warnings target smaller companies and leave the big boys alone, study finds ”






      A recent study has revealed that the warning letters issued by the US Food and Drug Administration (FDA) target small online retailers rather than large e-cigarette brands or products most used by young people, such as disposables and pods.

      FDA warnings to e-cigarette companies in 2020 and 2021 were almost all sent to small online retailers, according to analysis by the Truth Initiative.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik